Please wait a minute...
文章检索
预防医学  2017, Vol. 29 Issue (4): 351-354    DOI: 10.19485/j.cnki.issn1007-0931.2017.04.007
  论著 本期目录 | 过刊浏览 | 高级检索 |
2型糖尿病患者慢性并发症与脑卒中发病的关系
朱秋荣,徐惠庆,骆田斌,余梦华
嘉兴市秀洲区疾病预防控制中心,浙江嘉兴 314000
A study on the relationship between chronic complications of type 2 diabetic and stroke incidence
ZHU Qiu-rong,XU Hui-qing,LUO Tian-bin,YU Meng-hua
The Center for Diseases Control and Prevention of Xiuzhou District, Jiaxing,Zhejiang,314000, China
全文: PDF(519 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2型糖尿病(T2DM)患者慢性并发症与脑卒中发病的关系。方法 从浙江省慢性病监测管理信息系统导出2009—2014年嘉兴市秀洲区T2DM病例资料,主要包括患者基本信息、糖尿病慢性并发症和脑卒中发病情况。采用Logistic回归模型分析T2DM患者慢性并发症与脑卒中发病的关系。结果 共纳入T2DM患者6 108例,新发脑卒中462例,占7.56%;479例(7.84%)在糖尿病确诊时已出现慢性并发症,其中116例发生脑卒中,发生率为24.21%,高于无慢性并发症者6.15%(P<0.05)。各类型慢性并发症中血管病变比例最高,占33.33%;其次为肾脏病变和神经病变,分别占24.64%和23.23%;视网膜病变和皮肤感染分别占13.48%和5.32%。多因素Logistic回归分析显示,在调整性别、发病年龄、职业、城乡、肥胖、高血压和高血脂等因素后,血管病变(OR=4.95,95%CI:3.41~7.19)和神经病变(OR=2.79,95%CI:1.80~4.32)是T2DM患者发生脑卒中的危险因素;伴有慢性并发症是T2DM患者发生脑卒中的危险因素,伴有1、2、3项并发症的OR值分别为1.28、2.75、5.38。结论 T2DM患者在确诊时所伴有的血管病变和神经病变是导致脑卒中发病的危险因素,合并慢性并发症数量越多发生脑卒中的风险越大。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
朱秋荣
徐惠庆
骆田斌
余梦华
关键词 2型糖尿病脑卒中慢性并发症    
AbstractObjective To learn the relationship between chronic complications of type 2 diabetic and stroke incidence.Methods Based on the surveillance data of type 2 diabetes and stroke in Xiuzhou district of Jiaxing City from 2009 to 2014, using logistic regression model method to analysis the relationships between chronic complications of type 2 diabetic and stroke incidence.Results Among 6 108 participants, 462 subjects developed stroke (7.56%); 479 (7.84%) diabetes patients were diagnosed with chronic complications simultaneously and 116 subjects developed stroke (24.21%), higher than those no chronic complications (6.15%, P<0.05). The proportion of diabetic vasculopathy, nephropathy, neuropathy, retinopathy and skin infection were 33.33%, 24.64%, 23.23%, 13.48% and 5.32%, respectively. After adjusted for gender, age, occupation, urban and rural, obesity, hypertension and hyperlipidemia, there were significant statistical correlations between vasculopathy, neuropathy and stroke, the OR values and 95%CI were 4.95(3.41-7.19) and 2.79(1.80-4.32);patients who combined with any one,two, three or more chronic complications were significantly associated with the onset of stroke when compared with those without chronic complication, the OR values were 1.28, 2.75 and 5.38, respectivelyConclusion Vasculopathy and neuropathy of type 2 diabetes patients which found at diagnosed were risk factors of stroke,and the more for type 2 diabetes patients combined with the chronic complications, the greater the risk of stroke.
Key wordsType 2 diabetic    Stroke    Chronic complications
          出版日期: 2017-04-15
中图分类号:  R587.1  
  R743.3  
作者简介: 朱秋荣,硕士,医师,主要从事慢性病防制工作
通信作者: 骆田斌,E-mail:luo1981@yeah.net   
引用本文:   
朱秋荣, 徐惠庆, 骆田斌, 余梦华. 2型糖尿病患者慢性并发症与脑卒中发病的关系[J]. 预防医学, 2017, 29(4): 351-354.
ZHU Qiu-rong, XU Hui-qing, LUO Tian-bin, YU Meng-hua. A study on the relationship between chronic complications of type 2 diabetic and stroke incidence. Preventive Medicine, 2017, 29(4): 351-354.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn1007-0931.2017.04.007      或      https://www.zjyfyxzz.com/CN/Y2017/V29/I4/351
[1]NING G, BLOOMGARDEN Z. Diabetes in China: prevalence, diagnosis, and control [J]. J Diabetes, 2013, 5(4):372. [2]MATTHEWS D R, MATTHEWS P C. Banting Memorial Lecture: reply from Matthews and Matthews. Type 2 diabetes as an ' infectious disease: is this the Black Death of the 21st century?[J]. Diabet Med, 2011, 28(7): 880. [3]中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2010年版)[J]. 中国医学前沿杂志(电子版), 2011,20 (6):1227-1245.
[4]FONVILLE S, ZANDBERGEN A A, VERMEER S E, et al. Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke[J]. Cerebrovasc Dis,2013, 36(4): 283-289.
[5]KAMALESH M, SHEN J, ECKERT G J. Long term postischemic stroke mortality in diabetes: a veteran cohort analysis [J]. Stroke, 2008, 39(10): 2727-2731.
[6]ALLEN N B, HOLFORD T R, BRACKEN M B, et al. Geographic variation in one-year recurrent ischemic stroke rates for elderly Medicare beneficiaries in the USA [J]. Neuroepidemiology, 2010, 34(2): 123-129.
[7]LO S F, CHU S W, MUO C H, et al. Diabetes mellitus and accompanying hyperlipidemia are independent risk factors for adhesive capsulitis: a nationwide population-based cohort study(version 2)[J]. Rheumatol Int, 2014, 34(1): 67-74.
[8]中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治指南2010[J]. 中华神经科杂志,2010,43(2):146-153.
[9]陈春明, 孔灵芝. 中国成人超重和肥胖症预防控制指南[M]. 北京: 人民卫生出版社, 2006: 1-35.
[10]American Diabetes Association. Standards of Medical Care in Diabetes-2014[J]. Diabetes Care, 2014, 37(suppl 1):S14-S80.
[11]ACCORD STUDY GROUP, CUSHMAN W C, EVANS G W, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus [J]. N Engl J Med, 2010, 362(17): 1575-1585. [12]UDELL J A, SCIRICA B M, BRAUNWALD E, et al. statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus [J]. Clin Cardiol, 2012, 35(12): 722-729.
[13]GREGG E W, LI Y, WANG J, et al. Changes in diabetes-related complications in the United States, 1990-2010[J]. N Engl J Med, 2014, 370(16): 1514-1523.
[14]TAM V H, LAM E P, CHU B C, et al. Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus [J]. J Diabetes Complicat, 2009, 23(3): 185-193.
[15]邵永强. 社区人群糖尿病患病率及危险因素研究[J]. 浙江预防医学, 2011, 23(2): 3-6.
[16]张雪冰, 母义明, 李洪梅. 2型糖尿病与缺血性脑卒中[J]. 中华临床医师杂志(电子版), 2015, 9(12): 103-106.
[17]ZHUO L, ZOU G, LI W, et al. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus[J]. Eur J Med Res, 2013, 18(1): 4.
[18]陆艳艳. 肥胖型2型糖尿病与脑血管病变的相关性研究[D]. 苏州:苏州大学,2014.
[19]KANNO A, KIKUYA M, OHKUBO T, et al. Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study[J]. Nephrol Dial Transplant, 2012,27(8): 3218-3223.
[20]LIM C C, TEO B W, ONG P G, et al. Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population[J]. Eur J Prev Cardiol, 2015, 22(8):1018-1026.
[21]纪立农. 对2型糖尿病新的大型临床试验结果的解读和分析[J]. 中国糖尿病杂志, 2008,16(11):642-647.
[22]潘劲,胡如英,龚巍巍,等. 浙江省2007至2012年糖尿病流行特征的描述性分析[J].中华内分泌代谢杂志, 2015, 31(10): 846-850.
[1] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[2] 陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[3] 张凯慧, 李婉玲, 王彦兴, 安愿. 老年2型糖尿病患者心理灵活性、运动自我效能在衰弱与社会疏离间的中介效应分析[J]. 预防医学, 2025, 37(8): 783-788.
[4] 楚楚, 徐红, 蔡波, 韩颖颖, 穆海祥, 郑会燕, 林玲. 中老年人群脑卒中风险预测模型研究[J]. 预防医学, 2025, 37(7): 649-653.
[5] 刘明坤, 张丰香, 韩彩静, 王霞, 陈世坤, 金梅, 孙金月. 2型糖尿病患者周围神经病变风险预测模型研究[J]. 预防医学, 2025, 37(7): 692-696.
[6] 俞丹丹, 杨加丽, 张雅萍, 许慧琳, 何丹丹, 李俊. 2型糖尿病共病患者空腹血糖波动轨迹的影响因素研究[J]. 预防医学, 2025, 37(6): 562-567,572.
[7] 李美琳, 周梦姣, 吴佳芸, 喻喆, 孔利萍. 老年男性2型糖尿病患者合并肌少症的影响因素分析[J]. 预防医学, 2025, 37(6): 588-592.
[8] 任露露, 顾嘉昌, 闵艺璇, 张思晨, 乔健健, 肖月, 胡静. 2016—2023年宜兴市脑卒中发病趋势分析[J]. 预防医学, 2025, 37(5): 498-502.
[9] 陆丽君, 袁磊, 李殿江, 卢昆, 朱怡萱, 王志勇, 刘思浚. 老年2型糖尿病患者自我效能、自我管理行为在抑郁症状与血糖控制间的中介效应分析[J]. 预防医学, 2025, 37(5): 455-459.
[10] 王英杰 综述, 孙高峰, 审校. 2型糖尿病预测模型研究进展[J]. 预防医学, 2025, 37(4): 369-372,377.
[11] 孙霞, 但玲英, 郑鹏, 陈薪伊. 2型糖尿病患者脂肪因子与糖尿病视网膜病变的关联研究[J]. 预防医学, 2025, 37(3): 248-252.
[12] 陈海苗, 马岩, 刘明奇, 马珊珊, 李军, 方益荣. 儿童期肥胖与2型糖尿病、冠心病的孟德尔随机化研究[J]. 预防医学, 2025, 37(3): 307-311.
[13] 文进博, 张婷, 赵倩, 刘景, 孙中明, 侯建斌, 陆正权, 许雨婷, 马新雄, 潘恩春. 2型糖尿病患者运动处方干预效果评价[J]. 预防医学, 2025, 37(12): 1211-1216.
[14] 杨丽雅, 杜厉英, 张亚当, 姜灵芝. 2型糖尿病患者西格列汀联合二甲双胍与门冬胰岛素联合二甲双胍干预效果比较[J]. 预防医学, 2025, 37(10): 1054-1058.
[15] 王英杰, 孙高峰, 赵娥, 田原. 2017—2021年乌鲁木齐市2型糖尿病患者管理指标分析[J]. 预防医学, 2025, 37(1): 92-95.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed